mapo
- Jupiter Neurosciences (JUNS) shares closed 37% higher following the company’s $11M initial public offering on Tuesday.
- The Florida-based drug developer said it offered 2.75M shares priced at $4 per share, raising around $11M.
- Shares of the company began trading on